Home Blog Page 2705

A NEW CHAPTER FOR OCEANCO: NEW SHAREHOLDER GABE NEWELL

By
Advertorial Desk
-

ALBLASSERDAM, Netherlands, Aug. 1, 2025 /PRNewswire/ — Oceanco, one of the world’s leading custom yacht builders, is entering a new chapter with Gabe Newell – founder of Valve, tech pioneer, and longtime supporter.

Over the past 15 years, under the stewardship of the Barwani family, Oceanco has delivered some of the most iconic yachts — including Kaos, Bravo Eugenia, Black Pearl and Koru. With this foundation in place, it’s time for Oceanco’s next ownership. The Barwani family will remain active in the yachting world through their continued ownership of Turquoise Yachts, the leading Turkish custom yacht builder.

Gabe Newell is not entering this world as a financier or a strategist, but as a hands-on visionary who respects the sea, the craft, and above all, the people who make it possible. He wants Oceanco to continue on what it already does best: placing people first. This is not about buying a yacht company. It’s about plugging into a team and exploring what kind of future they can create when nothing holds them back.

Human-first. Ocean-minded. Future-focused.

Welcome to Oceanco’s next journey.

IMAGES

A selection of images are available for download here

CONTACT
Paris Baloumis, Group Marketing Director
Paris.Baloumis@oceanco.mc/+31 78 69 95 399
www.builtbyoceanco.com

Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson’s Disease

By
Advertorial Desk
-
  • The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pharmacokinetics of the investigational drug in 24 healthy subjects.
  • The results confirmed the favorable safety and tolerability profile of ENERGI-F705PD and successfully validated its sustained-release oral formulation.
  • Energenesis plans to advance ENERGI-F705PD into a Phase II trial.

TAIPEI, Aug. 1, 2025 /PRNewswire/ — Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biotechnology company focused on cellular energy restoration therapeutics, today announced the successful completion of its Phase I clinical trial for ENERGI-F705PD, an oral investigational drug candidate for Parkinson’s disease (PD). The Phase I study demonstrated favorable safety and tolerability in healthy volunteers, marking a significant milestone in the development of ENERGI-F705PD and reaffirming its potential as a disease-modifying therapy that targets intracellular alpha-synuclein aggregation. Energenesis Biomedical plans to submit a Phase II clinical trial application in 2025 to further evaluate the therapeutic efficacy of ENERGI-F705PD in patients with Parkinson’s disease.

“Current treatments for Parkinson’s disease primarily target symptoms, while ENERGI-F705PD represents a novel therapeutic strategy with disease-modifying potential,” said Dr. Han-Min Chen, CEO & Founder of Energenesis Biomedical. “ENERGI-F705PD targets Parkinson’s disease by restoring cellular energy ATP levels, preventing cellular alpha-synuclein aggregation, and decreasing ROS levels for neuroprotection. This multi-pronged approach may significantly slow disease progression. The encouraging results from our Phase I trial bring us one step closer to delivering a meaningful treatment option for PD patients worldwide.”

About ENERGI-F705PD

ENERGI-F705PD is a novel small-molecule drug delivered in an oral sustained-release formulation. It is designed to enhance cellular ATP and antioxidant production by engaging the purine salvage, glycolysis, and pentose phosphate pathways. This multi-pronged mechanism of action directly addresses key pathological hallmarks of Parkinson’s disease:

  • Reduce and Prevent Alpha-synuclein Aggregation: Elevated ATP acts as a hydrotrope, helping prevent the intracellular aggregation of misfolded alpha-synuclein, a central pathogenic hallmark of PD.
  • Increase Reducing Power (antioxidant): ENERGI-F705PD upregulates the pentose phosphate pathway (PPP), leading to increased NADPH production and enhanced cellular antioxidant defense.
  • Increase Tyrosine Hydroxylase Expression/activity: By optimizing cellular energy metabolism and engaging the purine salvage pathway, ENERGI-F705PD also enhances the expression and activity of tyrosine hydroxylase (TH), the key enzyme in dopamine synthesis, thereby helping restore neurotransmitter levels in the brains of PD patients.

The Promise of Alpha-Synuclein Targeting in Parkinson’s Disease

Parkinson’s disease, affecting over 10 million people globally, currently has no cure, with existing treatments only managing symptoms. The accumulation of alpha-synuclein protein is a key hallmark of the disease, making it a highly promising target for new disease-modifying therapies that aim to fundamentally change its progression. This critical area is seeing significant research and development, including both small molecules and antibody-based investigational treatments. ENERGI-F705PD, as an oral small-molecule drug, offers key advantages over antibody therapies, including better blood-brain barrier penetration, convenient oral administration, direct intracellular targeting, and potentially more accessible manufacturing.

About Energenesis Biomedical

Energenesis Biomedical Co., Ltd. (TWSE: 6657) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics that restore cellular energy and activate intrinsic repair mechanisms. By combining proprietary small-molecule innovation with AI-driven drug repurposing, Energenesis Biomedical aims to accelerate the development of treatments for unmet medical needs across various therapeutic areas, including neurodegenerative diseases, chronic wounds, and rare disorders.

The company’s leading candidates include:

  • ENERGI-F705PD: Tablet for Parkinson’s disease (Preparing for Phase II)
  • ENERGI-F703DFU: Gel for Diabetic foot ulcers (Phase III)
  • ENERGI-F701: Tonic for Alopecia (Phase II completed)
  • ENERGI-F703EB: Cream for Epidermolysis bullosa (EB), granted FDA Orphan Drug and Rare Pediatric Disease designation, and EMA orphan designation (Preparing for Phase II)

For more information, please visit www.energenesis-biomedical.com/en

Contact: Business Development Team

Email: partnership@energenesis-biomedical.com

InMobi Achieves 80% Penetration Among China’s Top Gaming Publishers, Showcases Next-Gen Ad Innovation at ChinaJoy 2025

By
Advertorial Desk
-

SHANGHAI, CHINA – Media OutReach Newswire – 1 August 2025 – InMobi, a global leader in mobile advertising and AI-powered monetization, is taking center stage at ChinaJoy 2025, highlighting its unparalleled growth and unwavering commitment to the Chinese developer ecosystem. With over 80% penetration among China’s top 100 gaming publishers and near-complete publisher retention InMobi has acheived a two-fold increase in revenue for Chinese partners between H1 of 2024 and H1 of 2025. This impressive performance reinforces InMobi’s position as a preferred global growth partner for mobile publishers.

As Chinese apps continue to expand into global markets, InMobi is at the forefront of delivering the next generation of mobile experiences—offering high-impact, user-centric ad solutions and custom monetization strategies that drive measurable business outcomes. Attendees are invited to explore InMobi’s latest innovations and client success stories at ChinaJoy 2025.

Standing Out in a Competitive Landscape
In the fast-evolving mobile advertising space, InMobi’s full-stack ad platform—encompassing DSP, SSP, and owned-and-operated (O&O) media—distinguishes it from both local and international competitors. At the core of this differentiation is Helix AI, InMobi’s proprietary intelligence engine that powers ad decision-making and optimization at scale. Supported by a dedicated team of local experts, InMobi enables Chinese developers to reach, acquire, and monetize high-value users efficiently across global markets.

This distinct edge is delivering tangible results in the U.S. market. For instance, a leading gaming studio in China saw a 5% increase in ARPDAU for one of its top-performing titles after integrating InMobi’s SDK. s Another fast-growing mobile games platform exceeded its ROAS targets and successfully acquired high-LTV users by leveraging Helix-powered campaign optimization capabilities. In an industry known for churn, InMobi has maintained a remarkable 90%+ client retention rate, underscoring the platform’s reliability and value in the U.S. market.

“We’re incredibly proud of the growth we’ve helped unlock for our Chinese partners,” said Kunal Nagpal, Chief Business Officer at InMobi. “ChinaJoy is the perfect platform to showcase how our AI-driven solutions, global reach, and strong local presence are empowering developers to succeed on the world stage.”

Strategic Vision and Product Innovation
Looking ahead, InMobi is doubling down on its investment in China with a multi-faceted strategy that combines technological innovation, market expansion, and local expertise.

At ChinaJoy 2025, InMobi is excited to announce the upcoming launch of Helix AI, its next-generation artificial intelligence engine that powers AcquirePro and Re-EngagePro—two core solutions designed to deliver smarter, data-driven user acquisition and re-engagement across global audiences.

Simultaneously, InMobi’s, associate company Glance, is expanding its Glance Ads offering, unlocking new monetization opportunities in India and Southeast Asia through platforms like Glance, Roposo, and Nostra. Earlier this year, Glance launched Glance AI, an AI commerce platform that creates an inspiration-led shopping experience for the emerging ‘AI consumer.’ The app is available in 140 countries and has been integrated with Motorola Edge phones in India and select Sharp models in Japan, with plans for further collaborations. Built on an open architecture, Glance AI transforms devices into smart commerce solutions and will soon expand into beauty and travel categories.

To further strengthen its execution in China, InMobi has appointed Grace Gui as Head of DSP Business for China, ensuring that partners benefit from local strategic support backed by global scale.

Visit InMobi at ChinaJoy
InMobi welcomes all ChinaJoy attendees, where they can experience live demos of Helix AI, discover how InMobi is empowering Chinese developers accelerate global success, and engage with both the local leadership team and global product experts. The booth will serve as a hub for collaboration, strategic discussions, and innovation showcases—demonstrating how InMobi is redefining the mobile experience for both advertisers and users.

InMobi’s booth location:
B906, Hall W3 of Shanghai New International Expo Center (BTOB Business Negotiation Hall)

Hashtag: #InMobi

The issuer is solely responsible for the content of this announcement.

About InMobi

InMobi group is a leading provider of content, marketing, and monetization technologies that help businesses grow by building real connections with today’s mobile-first consumers. Its platforms—including InMobi Advertising, Glance, Roposo, and 1Weather—deliver engaging experiences across smart surfaces and enable brands and developers to drive results through intelligent, data-driven solutions.

With a presence across the US, Europe, India, Southeast Asia, and China, and over 17 years of innovation, InMobi continues to redefine mobile engagement for the world’s leading brands and app developers.

For more information, visit .

Zeekr Group Announces July 2025 Delivery Update

By
Advertorial Desk
-

HANGZHOU, China, Aug. 1, 2025 /PRNewswire/ — ZEEKR Intelligent Technology Holding Limited (“Zeekr Group” or the “Company”) (NYSE: ZK), the world’s leading premium new energy vehicle group, today announced its delivery results for July 2025.

In July, Zeekr Group delivered a total of 44,193 vehicles across its Zeekr and Lynk & Co brands, representing increases of 19.7% year-over-year and 2.7% month-over-month. This achievement was made possible by the trust and support of over 2 million cumulative users. Specifically, the Zeekr brand delivered 16,977 vehicles, while Lynk & Co delivered 27,216 vehicles.

On July 9, Zeekr Group introduced its groundbreaking Super Hybrid Technologies, built on the Company’s new full-stack SEA-S platform. This next-generation system features a revolutionary 900V high-voltage architecture and tri-silicon carbide-powered e-motors paired with a CATL Freevoy Super Hybrid Battery, setting industry benchmarks for charging speeds, acceleration, and noise and vibration control.

The Zeekr 9X will be the first model in the Zeekr lineup to incorporate this technology, delivering an impressive peak output of 1,030kW and 0-100 km/h acceleration in under 3.1 seconds. The Zeekr 9X also supports ultra-fast charging, achieving a 20% to 80% charge in approximately 9 minutes and a 10% to 80% charge in just 10.3 minutes, marking a major leap in performance and user experience.

About Zeekr Group

Zeekr Group, headquartered in Zhejiang, China, is the world’s leading premium new energy vehicle group from Geely Holding Group. With two brands, Lynk & Co and Zeekr, Zeekr Group aims to create a fully integrated user ecosystem with innovation as a standard. Utilizing its state-of-the-art facilities and world-class expertise, Zeekr Group is developing its own software systems, e-powertrain and electric vehicle supply chain. Zeekr Group’s values are equality, diversity, and sustainability. Its ambition is to become a true global new energy mobility solution provider.

For more information, please visit https://ir.zeekrgroup.com.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “future,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

Investor Relations Contact

In China:

ZEEKR Intelligent Technology Holding Limited
Investor Relations
Email: ir@zeekrlife.com

Piacente Financial Communications
Tel: +86-10-6508-0677
Email: Zeekr@thepiacentegroup.com        

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
Email: Zeekr@thepiacentegroup.com

Media Contact

Email: Globalcomms@zeekrgroup.com

 

DayOne and Gaw Capital Break Ground on Phase One of Hyperscale Tokyo Data Center Campus

By
Advertorial Desk
-

TOKYO, Aug. 1, 2025 /PRNewswire/ — DayOne, a Singapore-based global data center developer and operator, and Gaw Capital Partners, a multi-asset investment management firm focusing on real estate, growth equity, private credit, and infrastructure markets globally, today broke ground on Phase One building within Gaw Capital’s 80MW data center campus in Tokyo, Japan.

From left to right at the groundbreaking ceremony: Mr. Jimmy Yu, Senior Vice President, DayOne Data Centers, Mr. Andy Okada, Board of Director, DayOne Data Centers; Mr. William Huang, Chairman, DayOne Data Centers; (priest); Mr. Kenneth Gaw, President, Managing Principal, Gaw Capital Partners; Isabella Lo, Managing Director, Principal - Investments & Head of Japan, Gaw Capital Partners; Edward Law, Managing Director - Asset Management (APAC), Gaw Capital Partners; Daisuke Taniguchi, Managing Director - Head of Asset Management, Japan, Gaw Capital Partners; Nicholas Toh, Managing Director - Head of Data Center Platform, Asia (Ex-China), Gaw Capital Partners
From left to right at the groundbreaking ceremony: Mr. Jimmy Yu, Senior Vice President, DayOne Data Centers, Mr. Andy Okada, Board of Director, DayOne Data Centers; Mr. William Huang, Chairman, DayOne Data Centers; (priest); Mr. Kenneth Gaw, President, Managing Principal, Gaw Capital Partners; Isabella Lo, Managing Director, Principal – Investments & Head of Japan, Gaw Capital Partners; Edward Law, Managing Director – Asset Management (APAC), Gaw Capital Partners; Daisuke Taniguchi, Managing Director – Head of Asset Management, Japan, Gaw Capital Partners; Nicholas Toh, Managing Director – Head of Data Center Platform, Asia (Ex-China), Gaw Capital Partners

Strategically located in the Fuchu Intelligent Park, a well-established data center cluster less than 30km from central Tokyo, the campus will offer a total IT capacity of 80MW, with approximately 66,360 square meters of gross floor area. Upon completion, it will be among the largest data center developments in Fuchu City in terms of IT load.

Phase One building of the campus comprises a nine-story building featuring ten data halls with an IT capacity of 18MW and is targeted to be core and shell ready by mid-2027. NEC Facilities serves as the architect, with HASEKO Corporation appointed as the main contractor.  

This cutting-edge hyperscale facility integrates advanced cooling technologies and harnesses renewable energy sources to enhance energy efficiency. It aims to achieve leading ESG and operational certifications, including CASBEE, LEED and ISO50001 Energy Management, reinforcing the commitment to sustainability and innovation in next-generation digital infrastructure.

The groundbreaking ceremony was attended by senior representatives from DayOne, Gaw Capital, United Overseas Bank, Crédit Agricole Bank, HASEKO Corporation and NEC Facilities, including Mr. William Huang, Chairman of DayOne, and Mr. Kenneth Gaw, President and Managing Principal of Gaw Capital Partners. The event underscores the collective commitment of all partners to advancing Japan’s digital ecosystem and fostering greater regional connectivity.

Ms. Jamie Khoo, CEO of DayOne, remarked: “Today’s groundbreaking signifies the start of our inaugural project in Japan. This campus will deliver the foundational infrastructure needed to support the rapid growth of cloud, AI, and next-generation technologies in Japan and the region. It also represents an important step in expanding our global platform, following our successful execution of the SIJORI (Singapore-Johor-Riau Islands) strategy across Southeast Asia.”

Mr. Nicholas Toh, Managing Director – Head of Data Center Platform, Asia (Ex-China) of Gaw Capital Partners, emphasized, “This groundbreaking event marks an important milestone in Fuchu City’s digital evolution. This collaboration merges Gaw Capital’s global real estate experience with DayOne’s expertise in operating high-performance data centers, illustrating our joint dedication to crafting a world-class infrastructure to meet the escalating data processing demands catalyzed by the rise of generative AI in the region.”

Japan is one of the world’s largest Tier 1 data center markets, with Greater Tokyo serving as the nation’s primary digital hub due to its strong domestic and international connectivity With the groundbreaking of its first data center in Japan, DayOne reaffirms its position as a leading provider of high-performance digital infrastructure, marking a significant step in advancing the country’s data ecosystem.”

-END-

About DayOne

Headquartered in Singapore, DayOne is a data center pioneer that develops and operates next-gen digital infrastructure for industry leaders who demand reliable, cost-effective, and quickly scalable solutions. Our cutting-edge facilities empower hyperscalers and large enterprises to achieve rapid deployment and enhance connectivity, driving transformative engagement and innovation as we shape the future of industries. DayOne’s data centers are located across key markets, including Singapore, Johor (Malaysia), Batam (Indonesia), Greater Bangkok, Hong Kong SAR, Tokyo, and beyond.

ASPIRE for Lung Cancer launches the APAC Lung Cancer Policy Consensus as a regional call to action for improved lung cancer care

By
Advertorial Desk
-

SINGAPORE, Aug. 1, 2025 /PRNewswire/ — On 31st July 2025, a unified consensus document for improving lung cancer care in the Asia-Pacific (APAC) region was officially launched in Singapore, marking a pivotal moment in the regional fight against lung cancer. This represents the first comprehensive consensus for the region, an evidence-based agreement between stakeholders across the healthcare ecosystem that outlines shared priorities, strategies, and recommendations to elevate the standard of lung cancer care across diverse health systems.

Held on the eve of World Lung Cancer Day, the initiative involved over 43 contributors, including clinicians, academics, patient advocates, and health organisations across 14 APAC health systems.

Launch Highlights and Key Voices

The APAC Lung Cancer Policy Consensus was launched with keynote contributions from:

  • Dr Mary Bussell (TriMar Strategies), who delivered an overview of the global lung cancer consensus and its relevance to regional efforts
  • Mr Yannick Romero (Union for International Cancer Control – UICC), who contextualised the APAC consensus within the broader global lung health resolution, emphasising policy alignment and strategic integration
  • Ms Helena Wilcox (The Lung Cancer Policy Network – LCPN), who highlighted how the APAC framework enables regional advancement in care and partnership building
  • Mr Francis Goh (Lung Cancer Education and Advocacy for Patients – LEAP), Singapore) stressed the pivotal role of patient voices in shaping lung cancer policy and health system transformation
  • A/Prof Herbert Loong (Asia Pacific Coalition against Lung Cancer – APCLC) and Asst Prof Yeon Wook Kim (SNU Bundang Hospital), who provided an in-depth presentation on the consensus development process, five key pillars, and concrete calls to action


Lung cancer remains the leading cause of cancer-related deaths in the APAC region, and accounts for nearly 60% of global cases. With regional incidence projected to exceed 1.8 million by 2040, the need for a cohesive, regional strategy to combat the disease has never been more urgent. Furthermore, survival rates in the APAC region often lag behind global benchmarks, with five-year survival rates frequently below 20%. This fragmented landscape highlights the critical need for a coordinated approach, one that addresses the unique epidemiological, environmental, and healthcare challenges within the region.

The APAC Lung Cancer Policy Consensus is the result of an extensive collaborative process involving two expert working sessions, one patient workshop and a final expert voting session, with input from patients, clinicians and academic leaders across the region. The consensus lays out a unified policy framework anchored in five core principles, all aimed at driving sustainable, equitable improvements in lung cancer prevention, detection, treatment, and stigma reduction across the region.

Importantly, the APAC Consensus aligns closely with the Global Lung Cancer Consensus, which was first ratified at the 9th International Lung Cancer Network in 2023. By endorsing this global statement, the APAC region reaffirms its commitment to improving lung cancer outcomes.

The Five Global Principles Anchoring the APAC Lung Cancer Policy Consensus:

  1. Improve and Expand Prevention
  • Strengthen tobacco control, public education, and environmental risk research to prevent lung cancer across all exposure types
  • Focus on Early Detection
    • Expand screening and diagnostic access through inclusive guidelines and innovative technologies to enable timely lung cancer detection
  • Ensure Equitable & Sustainable Access to Treatment
    • Promote timely, affordable access to modern and personalised lung cancer treatments across diverse healthcare settings
  • Build Partnerships and Promote Investment
    • Foster cross-sectoral collaboration and advocacy to drive investment and policy reform in lung cancer care
  • Combat Stigma, Recognising Lung Cancer as a Social Determinant of Public Health
    • Address stigma through education and empowerment to support early diagnosis, treatment adherence, and community acceptance

    A Region-Specific Approach to Lung Cancer Care

    The APAC Lung Cancer Policy Consensus is not just a regional adaptation of global recommendations; it is a comprehensive response to the distinct challenges faced by the APAC region. Unlike Western health systems that primarily focus on smoking-related lung cancer, the APAC region must contend with a higher prevalence of lung cancer in never-smokers due to factors such as environmental pollutants, and genetic predispositions. Moreover, the region’s healthcare systems are highly heterogeneous, ranging from well-resourced settings with cutting-edge cancer care to lower-resource environments building on basic cancer services.

    Given these disparities, a one-size-fits-all approach would be ineffective. The APAC Lung Cancer Policy Consensus presents a regionally tailored action plan that offers specific strategies and targets to improve lung cancer care and outcomes, ensuring that every health system in the region, regardless of its capacity, can make progress toward the shared goals.

    “We call on policymakers, healthcare leaders, and stakeholders across the APAC region to urgently prioritise and implement policies that improve lung cancer outcomes. While the specific solutions will vary across health systems, this consensus provides a shared foundation to guide national efforts. By acting now and adapting these recommendations to local contexts, we can foster a future where healthcare systems of all sizes work together to overcome regional challenges.” said Judy Li, Consortium Manager at ASPIRE for Lung Cancer.

    Looking Ahead

    The launch of the APAC Lung Cancer Policy Consensus marks the start of a sustained regional effort to transform lung cancer care in the Asia-Pacific region. Over the coming months, ASPIRE for Lung Cancer and its partners will continue to engage with policymakers, healthcare leaders, and patient advocacy groups to ensure that the consensus principles are translated into concrete action, with measurable outcomes.

    Through this regional collaboration, APAC aims to drive meaningful change that will improve survival rates and quality of life for lung cancer patients across the region.

    For more details about the APAC Lung Cancer Policy Consensus or to learn how you can get involved in advancing lung cancer care in your region, visit https://www.aspirelungcancer.com/ 

    About ASPIRE for Lung Cancer

    ASPIRE (Asia Pacific Policy Review and Engagement) for Lung Cancer is a collaborative multilateral effort focused on improving lung cancer outcomes in the Asia-Pacific region through policy reforms. We advocate for prioritising lung cancer in government action plans, aiming to drive transformative changes that enhance patient access and care.

    We believe in the influence of collaboration and collective action to drive positive change. We therefore work with governments, agencies, NGOs and patient groups, bringing together multi-disciplinary experts to improve health outcomes for lung cancer patients in the APAC region.

    CONTACT: ASPIRE for Lung Cancer, aspire.secretariat@eq-health.com

    Fresver Beauty Relocates Tampines Outlet to Simei to Meet Rising Demand for Personalised Wellness in the East

    By
    Advertorial Desk
    -

    SINGAPORE – Media OutReach Newswire – 1 August 2025 – Fresver Beauty, a trusted name in Singapore’s wellness and facial care industry since 1988, has relocated its Tampines outlet to a larger and more accessible space in Simei. The new outlet officially opened on 23rd July 2025, a move aimed at meeting growing demand in the East while enhancing customer comfort, accessibility, and service delivery.

    Fresver Beauty Relocates Tampines Outlet to Simei to Meet Rising Demand for Personalised Wellness in the East
    Fresver Beauty Relocates Tampines Outlet to Simei to Meet Rising Demand for Personalised Wellness in the East

    This new location is conveniently surrounded by essential amenities, including major supermarkets, a wide variety of eateries, and family-friendly establishments, making it a vibrant and accessible spot for customers to enjoy personalised facial and wellness sessions without disrupting their daily routine.

    Purpose-Driven Relocation to Enhance Capacity and Customer Experience
    Fresver Beauty’s decision to relocate is rooted in a sharp increase in demand for its award-winning facial treatments and personalised wellness services. The new Simei outlet, now equipped with 9 treatment rooms, allows for greater capacity and improved scheduling flexibility, ensuring a more seamless and comfortable experience for every customer.

    “This relocation wasn’t just a change in address—it was a strategic move to serve our customers better.” “We responded to what our clients need: more space, more services, and a more convenient experience from the moment they step out of the MRT.”

    The move has also allowed Fresver Beauty to reach new groups of customers, including airline service crew members who appreciate the outlet’s accessibility and peaceful environment—a welcome escape in between hectic travel schedules.

    With its calming interiors, thoughtfully designed layout, and modern facilities, the Simei outlet is built to deliver elevated personalised wellness experiences in every visit.

    A New Chapter of Beauty and Wellness Begins
    With the Simei outlet now open, Fresver Beauty marks a fresh milestone in its journey to bring trusted, effective, and heartfelt care to more customers. The new space not only allows for greater treatment capacity, but also provides a calm and inviting environment that many, both new and existing customers, have come to appreciate.

    Among them is Ms Caroline, a long-time client of over 12 years. She shared, “I’ve been with Fresver Beauty for over a decade, and I must say, the new Simei outlet is a wonderful change. It’s spacious, peaceful, and incredibly convenient. Every visit feels like a treat, and I truly appreciate the thought that went into creating this new space.”

    This latest move reaffirms Fresver Beauty’s continued commitment to evolving with the needs of its community, offering not just beauty solutions but holistic experiences that restore, renew, and uplift.
    Hashtag: #FresverBeauty #Facial #BodyWellness #SimeiFacial



    The issuer is solely responsible for the content of this announcement.

    About Fresver Beauty

    Established in 1988, Fresver Beauty is a trusted provider of premium beauty and wellness services in Singapore. With over three decades of experience, the brand has built a strong reputation for delivering personalised, results-driven treatments, including , and more that blend expert techniques with high-quality skincare products. The brand’s dedicated team of professionals adopts a holistic and effective approach, addressing each client’s unique beauty and wellness needs. Fresver Beauty remains committed to helping clients look and feel their best, offering not just treatments but a complete pampering experience rooted in care, quality, and excellence.

    Zoe Energy Storage Secures BNEF Tier 1 Ranking Again

    By
    Advertorial Desk
    -

    One-Stop Global Services Accelerate Green Transition Worldwide

    SHANGHAI, Aug. 1, 2025 /PRNewswire/ — BloombergNEF (BNEF), the globally recognized authority in clean energy research, today released its Energy Storage Tier 1 List for Q3 2025. Zoe Energy Storage has secured its position on this prestigious global ranking for the second consecutive time, reaffirming its leadership in technological innovation, product excellence, robust project delivery capabilities, and expanding market competitiveness. This achievement marks renewed international recognition of Zoe’s comprehensive strength in the global energy storage sector.

    The BNEF Tier 1 certification is widely regarded as the industry’s gold standard, serving as a critical reference for financial institutions in commercial lending decisions. Its rigorous assessment evaluates core competencies including project bankability, technological originality, product reliability, deployed project scale, and global operational footprint. Zoe’s sustained leadership underscores its formidable end-to-end advantages – from cutting-edge R&D to large-scale commercialization – in an intensely competitive global market.

    Committed to delivering full lifecycle value, Zoe provides clients with integrated solutions: from green financing consultation during project development, through scenario-specific system design and integration, to post-commissioning operational support and maintenance. Its one-stop service model has gained trust across 30+ countries and 70+ cities worldwide, serving 100+ industry segments spanning commercial & industrial and utility-scale applications. Additionally, Zoe partners with leading global insurers to provide comprehensive safety guarantees throughout project lifecycles.

    Looking ahead, Zoe will intensify R&D investments in core storage technologies and diversified product portfolios to deliver more advanced, reliable, and efficient solutions. “We remain focused on addressing diverse global application needs,” stated a company spokesperson. “Through continuous innovation and exceptional service, we are committed to powering high-quality, sustainable growth in the energy storage industry while advancing global carbon neutrality goals.”

    About Zoe Energy Storage
    As a global Tier 1 energy storage integration and solution provider, Zoe’s flagship Z BOX product series meets stringent international safety and quality certifications. The company operates a fully integrated value chain from R&D and certification to mass deployment, delivering secure and cost-effective energy storage systems worldwide.

    1...2,7042,7052,706...6,334Page 2,705 of 6,334